Why the study?
Do pharmacologic treatments improve stuttering?
Do pharmacologic treatments improve stuttering?
A critical review of pharmacologic treatments for stuttering highlights the lack of adequate experimental designs and suggests calcium channel blockers and cholinergic drugs as promising research avenues.
Stuttering pharmacotherapy lacks proven options; leaves open calcium channel blockers and cholinergic agents for future rigorous trials.
OBJECTIVE: The author critically examines the limited world literature on pharmacologic treatments of stuttering. METHOD: The literature on stuttering and drugs was identified by means of two computer-assisted searches. FINDINGS: A great variety of pharmacologic agents have been used to treat stuttering, reflecting the many theories about the origin and nature of the disorder. In some instances new hypotheses about the nature of stuttering have followed the chance discovery of agents having some efficacy. CONCLUSIONS: Few studies have used adequate experimental designs. Promising avenues of research, both for the treatment of stuttering and for exploring its nature, include the use of calcium channel blocking agents and cholinergic drugs.
No takes yet. Share an insight, caveat, or question.
John Paul Brady (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: